6BYZ
Structure of Cysteine-free Human Insulin-Degrading Enzyme in complex with Substrate-selective Macrocyclic Inhibitor 37
Experimental procedure
Experimental method | MAD |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 12.3.1 |
Synchrotron site | ALS |
Beamline | 12.3.1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-10-09 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 1.116 |
Spacegroup name | P 65 |
Unit cell lengths | 264.486, 264.486, 91.094 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 48.480 - 2.956 |
R-factor | 0.162016770659 |
Rwork | 0.161 |
R-free | 0.20263 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4lte |
RMSD bond length | 0.006 |
RMSD bond angle | 0.843 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | PHENIX (1.11.1_2575) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 48.480 | 3.062 |
High resolution limit [Å] | 2.956 | 2.956 |
Number of reflections | 148881 | 7521 |
<I/σ(I)> | 16.34 | 1.91 |
Completeness [%] | 99.8 | 98.88 |
Redundancy | 12.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6.8 | 298 | 0.1 M HEPES, 12% Tacsimate, 20% PEGMME-5000, 10% 1,4-dioxane |